Kenvue Inc
J&J to spin off orthopedics business, raises full-year forecast
Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years. The health-care conglomerate also raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations. The company […]
Read More
Stocks making the biggest premarket moves: Paccar, Intel, RH, Riot Platforms and more
Check out the companies making the biggest moves in premarket trading: Paccar — The maker of Peterbilt trucks jumped 7% after President Donald Trump said slapped a 25% tariff on imported heavy trucks starting Oct. 1. Intel — The chip company added 4.4%. The Wall Street Journal reported Intel has approached Apple , Taiwan Semiconductor […]
Read More
Stocks making the biggest moves midday: Firefly Aerospace, AutoZone, Sempra, Halliburton and more
Check out the companies making headlines in midday trading: Baker Hughes , Halliburton — Oil services stocks including Halliburton and Baker Hughes traded higher as oil prices looked to break a four-day losing streak. Baker Hughes’ stock rose more than 4%, while Halliburton and Transocean each added 8%. Sempra — Shares of the energy company […]
Read More
Stocks making the biggest moves premarket: Firefly Aerospace, AutoZone, Kenvue & more
Check out the companies making headlines before the bell: Firefly Aerospace — The aerospace company fell more than 10% after posting its first quarterly report since going public last month. Firefly saw a wider loss and lower revenue than expected for the second quarter. AutoZone — The automotive parts retailer fell 2% after its gross […]
Read More
Trump admin draws unproven link between autism and Tylenol ingredient use during pregnancy
In this photo illustration, Tylenol caplets are displayed on Sept. 22, 2025 in San Anselmo, California. Justin Sullivan | Getty Images The Trump administration on Monday drew an unproven link between autism and pregnant women’s use of acetaminophen, the active ingredient in one of the world’s most common over-the-counter pain relievers, Kenvue’s Tylenol. President Donald […]
Read More
Stocks making the biggest moves midday: Oracle, Apple, Metsera, Compass, Kenvue and more
Check out the companies making headlines in midday trading : Better Home & Finance Holding — The mortgage lender briefly soared as much as 176% Monday after hedge fund manager Eric Jackson in a social media post on X called Better Home “the Shopify of mortgages” and said the company is rebuilding a $15 trillion […]
Read More
Stocks making the biggest premarket moves: Metsera, Compass, Kenvue, Fox & more
Check out the companies making headlines before the opening bell : Metsera , Pfizer — The weight-loss drugmaker soared 60% after an announcement it would be bought by Pfizer for $4.9 billion in cash. The deal is expected to close in the fourth quarter. Pfizer shares ticked nearly 3% higher. Anywhere , Compass — Brokerage […]
Read More
Trump administration reportedly plans to link autism to Tylenol use during pregnancy
Tylenol is displayed for sale at a pharmacy in New York City, New York, U.S., September 5, 2025. Kylie Cooper | Reuters The Trump administration plans to announce Monday that pregnant women’s use of Tylenol is potentially linked to autism, according to The Washington Post. Federal health officials are expected to warn women against using […]
Read More
Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy
Kenvue Inc. Tylenol brand pain reliever for sale at a pharmacy in New York, US, on Wednesday, March 27, 2024. Bloomberg | Bloomberg | Getty Images Shares of Kenvue fell more than 10% on Friday after a report that Health and Human Services Secretary Robert F. Kennedy Jr. will likely link autism to the use […]
Read More
Stocks making the biggest moves premarket: Kenvue, Rivian, Affirm, SolarEdge Technologies and more
Check out the companies making headlines in premarket trading. Kenvue — The Neutrogena-maker jumped 4.5% after the company said its CEO Thibaut Mongon has stepped down . Kenvue said its board is conducting a strategic review of the company and is considering a range of possible alternatives, such as simplifying the company’s portfolio. nCino — […]
Read More